 Connection
Kirk Hansen to Fibronectins
This is a "connection" page, showing publications Kirk Hansen has written about Fibronectins.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.162 |
|
|
|
-
Ginocchio S, McCabe MC, Flockton AR, Gumina DL, Hansen KC, Ji S, Su EJ. Unraveling the Matrix: Proteomic Profiling Reveals Stromal ECM Dysregulation in Severe Early-Onset Fetal Growth Restriction. Int J Mol Sci. 2025 Nov 19; 26(22).
Score: 0.055
-
Smith CF, Baldé MA, French S, Modahl CM, Bahrabadi L, Amponsah-Asamoah M, Larson KY, Maroney SP, Galindo DC, Millimouno M, Camara N, Benjamin J, Brandehoff NP, McCabe MC, Cohen MJ, Jackson K, Baldé C, Castoe TA, Mackessy SP, Hansen KC, Saviola AJ. Discerning specific thrombolytic activities and blood clot degradomes of diverse snake venoms with untargeted peptidomics. J Thromb Haemost. 2025 07; 23(7):2198-2212.
Score: 0.053
-
Tarullo SE, Hill RC, Hansen KC, Behbod F, Borges VF, Nelson AC, Lyons TR. Postpartum breast cancer progression is driven by semaphorin 7a-mediated invasion and survival. Oncogene. 2020 03; 39(13):2772-2785.
Score: 0.037
-
Hattar R, Maller O, McDaniel S, Hansen KC, Hedman KJ, Lyons TR, Lucia S, Wilson RS, Schedin P. Tamoxifen induces pleiotrophic changes in mammary stroma resulting in extracellular matrix that suppresses transformed phenotypes. Breast Cancer Res. 2009; 11(1):R5.
Score: 0.017
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|